NDC 0085-1519 – Temodar
Temozolomide 20 mg/1 · Capsule · Oral
Product NDC0085-1519
Product details
- Brand name
- Temodar
- Generic name
- Temozolomide
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- NDA · NDA021029
- Marketed since
- August 11, 1999
- Listing expires
- December 31, 2027
- Pharmacologic class
- Alkylating Drug
Active ingredients
- Temozolomide 20 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0085-1519-03 | 5 PACKET in 1 CARTON (0085-1519-03) / 1 CAPSULE in 1 PACKET (0085-1519-05) | Aug 11, 1999 |
| 0085-1519-04 | 14 PACKET in 1 CARTON (0085-1519-04) / 1 CAPSULE in 1 PACKET (0085-1519-05) | Aug 11, 1999 |
Recalls mentioning this NDC
- D-139-2013 Feb 6, 2013 · Class II
Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.
Other Temodar products
- 0085-1366 Temozolomide 100 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0085-1417 Temozolomide 250 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0085-1425 Temozolomide 140 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0085-1430 Temozolomide 180 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0085-3004 Temozolomide 5 mg/1 · Capsule · Merck Sharp & Dohme LLC
- 0085-1381 Temozolomide 2.5 mg/mL · Injection, Powder, Lyophilized, For Solution · Merck Sharp & Dohme LLC